AC Immune Holds its Annual General Meeting of Shareholders
LAUSANNE, Switzerland, June 25, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that AC Immune held its Annual General Meeting per Swiss law.
- LAUSANNE, Switzerland, June 25, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that AC Immune held its Annual General Meeting per Swiss law.
- Shareholders cast their votes through the independent proxy appointed by the shareholders.
- Douglas Williams, Chairman of the Board of Directors of AC Immune, commented: Despite impact from COVID-19, AC Immune has maintained its business on track.
- I am thankful to our Shareholders for their trust in the Board to lead AC Immune in its next phase of development.